biotechnetworks.org

GENERAL
META
KEYWORD DATA
BACKLINKS
HTML
LINK ANALYSIS
DOMAIN
SERVER

Biotechnetworks.org recives any estimated n/a unique visitors and n/a unique page views per day. Revenue gained from these much visits may be n/a per day from various advertising sources. The estimated worth of site is n/a.

Website Age 5 years, 5 months, 7 days
Alexa Rank no-data
Country United States
IP Address 35.215.74.219

META INFORMATION

Title

Biotech Networks

Description

Keywords

Content Type

utf-8

No	Meta Name	Value
1	viewport	width=device-width, initial-scale=1.0
2	robots	max-image-preview:large

Top Keywords in Search

Keyword	Position	Traffic %	Keyword Cost	Traffic Cost	Results
pendulum halle berry	65	0	18.049999237061	0	66900
marsha sottung	23	1.210000038147	0	0	719
arrakis therapeutics layoffs	38	0	0	0	39
neuragenix reviews	54	0	0	0	88
patent pmr-116	7	54.869998931885	0	0	83
hlth shake	78	0	2.9200000762939	0	285000000
parallel ent and allergy	63	0	12.630000114441	0	82
smartek21	84	0	0	0	95
indigo ag layoffs 2023	15	0	0	0	57
li boynton	7	3.6500000953674	0	0	1490000
astellas super bowl ad	34	0	0	0	76
health carousel lawsuit	20	0	0	0	346000
bucked up anime line	14	0	0	0	142000
doug melton vertex	71	0	0	0	18800
autumn bear acupuncture	25	0	0	0	515000
james wilson penn	82	0	0	0	16100000
skin laundry denver	42	0	2.5699999332428	0	3070000
emily robinson alison chao	9	8.5299997329712	0	0	485000
marsha sottung	36	0	0	0	719
is pmr-116 patented	24	2.4300000667572	0	0	64
emily robinson attorney alison chao	11	15.85000038147	0	0	50500
alumis biotech	93	0	0	0	18200
pmr-116 patent	15	10.970000267029	0	0	71
qiana williams ohsu	13	1.210000038147	0	0	84
job fair biotech	7	1.210000038147	2.0199999809265	100	3050000

Top backlinks

Backlink from Page: scienceinseattle.com/event/nanostring-life-science-career-fair-hosted-by-biotech-networks/
Link back to url: biotechnetworks.org/
Anchor Text: Biotech Networks
Link is Dofollow
External Links: 8
Backlinking Domain Category: Top/Computers

Backlink from Page: slonepartners.com/events-sponsorships/
Link back to url: biotechnetworks.org/
Anchor Text: Biotech Networks
Link is Dofollow
External Links: 10
Backlinking Domain Category: Top/Computers

Backlink from Page: mail.bizwireexpress.com/showstoryPRWeb.php?storyid=805776
Link back to url: biotechnetworks.org/
Anchor Text: Biotech Networks
Link is Nofollow
External Links: 7
Backlinking Domain Category: Top/Business

Backlink from Page: sfbn.org/
Link back to url: biotechnetworks.org/slider1
Anchor Text: ~img~
Link is Dofollow
External Links: 20
Backlinking Domain Category: Top/Science

GENERAL HTML INFORMATION

Type	Status
HTML 5
Responsive Website

HTML SIZE INFORMATION

Text / Code Ratio 7.94 %

biotechnetworks.org has a website text/code ratio of 7.94 %. Search engine crawlers tend to not pick up pages with inadequate content.

IMPORTANT HTML TAGS AND COUNTS

Titles

No	Text
1	Follow/subscribe

No	Text
1	Biotech networks featured news
2	Biotech networks trending news: us west, mountain & midwest
3	Biotech networks trending news: us east

Text Styling

STRONG0
B0
EM0
I0
U0
CITE0

LINK ANALYSIS

Total Link Count: 164

Internal Link Count : 35

No	Text	Type
1	-	image
2	-	image
3	ADVERTIs*****T — Advertise With Biotech Networks	text
4	Home	text
5	About	text
6	About	text
7	Biotech Networks News	text
8	Become A Biotech Networks Partner	text
9	Biotech Networks Events	text
10	Partner	text
11	Advertise	text
12	Subscribe	text
13	Contact	text
14	[ June 7, 2022 ] Biotech Networks Launches Three New US Hubs for BIO 2022, Empowering the Life Science Industry to Make Vital Regional and Global Connections Biotech Networks Trending News	text
15	-	image
16	-	image
17	-	image
18	Biotech Networks Featured News	text
19	-	image
20	Mary’s (Good) Personal News & 2024-2025 Event Format Updates	text
21	July 1, 2024	text
22	-	image
23	Biotech Networks BD/Marketing Insights: Top 10 Tips We’ve Learned From Sending 1.85 Million Marketing E-mails 📫 a Year	text
24	April 1, 2024	text
25	-	text
26	-	image
27	What is Demand Generation and Why Does My Life Science Company Need It?	text
28	April 1, 2024	text
29	-	text
30	-	image
31	-	image
32	POST A JOB	text
33	-	image
34	ADVERTIs*****T — Advertise With Biotech Networks	text
35	-	empty

External Link Count : 129

No	Text	Type
1	[ September 24, 2024 ] Modular Devices Welcomes Dan Dernbach as Senior Vice President of Cleanroom Operations Biotech Networks Trending News	text
2	[ September 24, 2024 ] Capricor to begin filing DMD drug with FDA next month; Surrozen’s $10M milestone News	text
3	[ September 24, 2024 ] Scoop: Sanofi hires Mike Quigley as next chief scientist, internal memo says News	text
4	[ September 24, 2024 ] TriLink BioTechnologies® & Alphazyme Collaborate to Launch New CleanScribe™ RNA Polymerase News	text
5	[ September 24, 2024 ] Revelation Biosciences’ Gemini Induces Dose Dependent Significant Increases in IL-10 News	text
6	UCLA research identifies new, potentially more effective approaches for treating skin cancer by simultaneously targeting multiple metabolic pathways	text
7	Genfit moves to jump-start enrollment in slow-going phase 2 liver failure trial	text
8	FUJIFILM Irvine Scientific Develops Oceo Rover: The First Automated Single-Use Hydration System for Media and Buffers	text
9	Upstream Bio files for IPO in sign of life for biotech public offerings	text
10	Believe Limited Named Finalist for Fierce Pharma's Agency of The Year Award	text
11	#ESMO24 roundup: New data on Amgen’s PRMT5 inhibitor seem lackluster, and Jazz’s HER2 antibody	text
12	Angelalign Technology Inc. Reports Strong Growth in Global Operations for 1H 2024	text
13	Los Angeles Center for Ear, Nose, Throat and Allergy Opens Palm Springs Office	text
14	Mozart Ther***utics secures $25M expansion to Series A; LianBio unveils PhIIa data for gastric cancer treatment	text
15	Aided by "Clean" FDA Label, US Dermatologists Report BMS' Sotyktu Has Potential to Delay Biologic Treatment in Plaque Psoriasis, According to Spherix Global Insights	text
16	Scoop: Sanofi hires Mike Quigley as next chief scientist, internal memo says	text
17	A VC-backed genetic testing startup to 'consider' making an offer to buy 23andMe	text
18	Sutro Biopharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	text
19	Biotech VC firm outlines plans for $100M fund	text
20	Cancer-focused biotech Notable Labs lays off 65% of workforce	text
21	'We Don't Care About San Francisco': LA Life Sciences Has A Supply Crunch	text
22	4DMT Highlights Robust and Durable Clinical Activity for 4D-150 and Design of 4FRONT Phase 3 Program at 4D-150 Wet AMD Development Day	text
23	All of 23andMe's independent board members resign over disagreements with CEO	text
24	Ex-Kite leaders step in at Kyverna as CEO exits after landing year's second-biggest IPO	text
25	*EVENT IS SOLD OUT*Biotech Networks Speed Networking: San Francisco & JPM January 8th 2024	text
26	Capricor to begin filing DMD drug with FDA next month; Surrozen’s $10M milestone	text
27	TriLink BioTechnologies® & Alphazyme Collaborate to Launch New CleanScribe™ RNA Polymerase	text
28	Revelation Biosciences’ Gemini Induces Dose Dependent Significant Increases in IL-10	text
29	Saving Elephants, Supporting Farmers: Fulbright National Geographic Award Sends Doctoral Student Sateesh Venkatesh to Sri Lanka	text
30	Millennium Health Signals Alert™ Shows Carfentanil Extends Deadly Reach	text
31	Qualia Launches Improved Version Of Its Flags***p Brain Health Formula Qualia Mind	text
32	Catherine Owen Adams Succeeds Steve Davis as CEO of Acadia Pharmaceuticals	text
33	Sanofi scoops negotiation rights to Ventyx obesity, Parkinson’s candidate for $27M	text
34	Context makes a T cell engager deal; Ginkgo Bioworks backers have a new SPAC	text
35	Is Sanofi making a move into obesity? French pharma invests $27M into Ventyx	text
36	Christus Health to take over Texarkana hospital	text
37	Genprex Featured in CEO/CFO Magazine Discussing Novel Gene Therapies for Cancer and Diabetes	text
38	Shokz Named Official Headphone Partner of the Bank of America Chicago Marathon	text
39	Actuate Announces Scientific Reports Publication on Elraglusib’s Novel Immunomodulatory Mechanism of Action as a GSK-3β Inhibitor	text
40	CorroHealth Finalizes Acquisition of Healthcare Revenue Cycle Management Business from Navient	text
41	Labcorp laying off 53 employees, closing recently acquired laboratory	text
42	Christus expands to Morgan’s Wonderland campus	text
43	Lexicon Pharmaceuticals President and COO Jeffrey Wade to step down	text
44	Houston Community College partners*p launches nursing pre-apprentices*p program	text
45	MDLive veterans nab $7.5M Series A for virtual specialty care startup	text
46	Halia Ther*utics Reveals Promising Preclinical Obesity Data: HT-6184 and Semaglutide Combination Enhances Weight Loss and Preserves Lean Muscle Ma*	text
47	Biotech VC firm outlines plans for $100M fund	text
48	Edgewise Ther***utics Announces Positive Top-Line Data from Phase 1 Trial in Healthy Subjects and Phase 2 CIRRUS-HCM Trial in Patients with Obstructive Hypertrophic Cardiomyopathy (HCM)	text
49	Viatris Announces the Pricing Terms of Maximum Tender Offer	text
50	Salon Freedom Announces Leaders***p Transition: Erin Bracke Named CEO, David Raduziner Moves to Vice Chair of the Board	text
51	Viatris Announces Early Tender Results and Increase of Pending Maximum Tender Offer	text
52	Fresh Tracks' board supports company liquidation, shareholder meeting in Q4	text
53	Denver wearable tech startup takes on investors, introduces Meta leader as advisor	text
54	Dr. Jennifer Strickland Fowler joins Destination Pet as CEO to lead the company's next phase of growth	text
55	Q&A: One year in, American Cancer Society's new leader sees a sharpened focus coming out of the Covid pandemic	text
56	Ludica Health Launches New Pickleball-Themed Game for Falls Prevention Week 2024	text
57	After Alzheimer’s stumble, Athira lays off 70% of workforce and pivots to ALS small molecule	text
58	Just – Evotec Opens Its First J.POD Facility in Europe	text
59	OHSU spinout gets $68M vote of confidence from investors	text
60	SetSet Launches World's First Clinician-Approved Community and Resource Platform to Make Psychedelics Safe for Women	text
61	Seattle council OKs drug use, prost**ution laws over experts' objections	text
62	NIH establishes pandemic preparedness network, plans up to $100M in yearly funding for work on new treatments and vaccines	text
63	Bad trip: How culture conflict and a need for cash nearly broke Lykos	text
64	Nura Bio raises $68M for clinical tests of SARM1 inhibitor to potentially slow or prevent nerve degeneration	text
65	Former GE executive buys mansion in Medina	text
66	To combat heart disease and cancer, genomics researcher looks abroad	text
67	Align ENT + Allergy Expands into Michigan	text
68	Remodel Health Launches ICHRA Academy™: Empowering Brokers to Lead with Confidence	text
69	GE HealthCare claims FDA clearance for amyloid imaging software in Alzheimer’s disease	text
70	Express Scripts sues FTC over report critical of PBM business practices	text
71	Axcelead DDP and Lilly Enter into Research and Collaboration Agreement	text
72	St. Louis-based nonprofit gets $14M federal grant to produce drug ingredients	text
73	Iantrek Announces 1-Year Clinical Results of Its Bio-Interventional Technology for Uveoscleral Outflow Enhancement in Open-Angle Glaucoma Patients	text
74	MBX Biosciences Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares	text
75	AANA Announces New RN/APRN Members***p Category	text
76	UK vaccine startup Vicebio snags $100M to take on GSK, Pfizer and Moderna	text
77	Regulatory RNA startup CAMP4 files for IPO as more biotechs line up listings	text
78	Lasker Award goes to three scientists who pioneered research behind GLP-1 drugs	text
79	Ma***. headcount among top 10 biopharma employers shrinks	text
80	Harbour BioMed Announces the Latest Clinical Data on the First-in-Cla*** Fully Human Anti-B7H7/HHLA2 Monoclonal Antibody HBM1020 at the ESMO Congress 2024	text
81	With $370M debut, Candid Ther***utics is upfront about goal to lead a coming T-cell engager wave	text
82	Biotech Networks Speed Networking Boston September 25th 2024	text
83	Metformin, common diabetes drug, not linked to increased birth defect risk	text
84	Mediterranean diet high in polyphenols linked with slower biological aging	text
85	MIT-Northpond Program created to advance innovation in engineering and life sciences	text
86	VerImmune Completes $4.5 Million First Closing of Pre-Series A Financing, Strengthens Board with Two Accomplished Biotechnology Executives	text
87	NIH awards $27M to establish new network of genomics-enabled learning health systems	text
88	Sirnaomics Announces Demonstration of a Novel Mechanism of Action of Its siRNA Ther***utics for Focal Fat Reduction in Journal of Cosmetic Dermatology	text
89	United We Care and Maryland Rural Health a***ociation Join Forces to Transform Mental Health Care in Rural Communities	text
90	Revolo Announces New Preclinical Data Further Validating Atopic Dermat**is as a Target Indication for ‘1104	text
91	Foundation Fighting Blindness Expands Giving Opportunities with Enhanced Financial Inst**ution Access for Donor-Advised Funds, Stock Donations, and Cryptocurrency	text
92	VaLogic Bio Acquires Facility Logix to Expand Life Sciences Facility Services	text
93	NextCure Presented Results of the Phase 1b Study of NC410 in Combination with Pembrolizumab at ESMO 2024	text
94	Mary’s Center CEO Tollie Elliott abruptly steps down	text
95	Grenova Announces Appointment of Richard Pellegrino as Chief Research and Development Officer	text
96	Sentara Health Plans and Quest Diagnostics Form Strategic Collaboration to Extend Lab Access in Parts of the Southeast	text
97	Health care company to close Boca Raton facility, lay off 56 workers	text
98	mRNA and Gene Editing Tools Offer New Hope for Dengue Virus Treatment	text
99	MDLive veterans nab $7.5M Series A for virtual specialty care startup	text
100	DEFENDANT FIGHTS BACK AGAINST MiMEDX "BLATANT INTIMIDATION" NON-COMPETE SUIT	text
101	Grant Funds University of Florida Research for Potential Opioid Relief	text
102	FASTer Way to Fat Loss Debuts Breakthrough Hydration Product with Celtic Sea Salt	text
103	Clearside Biomedical to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024	text
104	Tampa pharma company stacked with former McKesson execs launches IPO	text
105	Danish manufacturing firm breaks ground in Peachtree City; 200 new jobs expected	text
106	PTSD from Brain Injury Could Be Treated with Targeted Magnetic Stimulation	text
107	j***anese firm leans on North Carolina facility amid consolidation	text
108	Atrium Health buys entire block in Atlanta for $70 million	text
109	Roivant dermatology subsidiary to be acquired by Organon	text
110	United Ther***utics swells North Carolina footprint with $33M deal	text
111	Global company with NC operations to lay off hundreds	text
112	Colossal development along I-40 could create 1,600 jobs and transform North Carolina town	text
113	Global firm with North Carolina operations to lay off hundreds	text
114	Maggots, other violations reported at drug facility in North Carolina	text
115	CFO Anthony DeFurio resigns at Atrium Health parent company Advocate	text
116	Highmark Health gives $490K in grants to several nonprofits	text
117	Context makes a T cell engager deal; Ginkgo Bioworks backers have a new SPAC	text
118	UK vaccine startup Vicebio snags $100M to take on GSK, Pfizer and Moderna	text
119	European regulators reaffirm Apellis’ rejection, add 8 positive recommendations	text
120	Advancing Pediatric Care Through Technology: Office Practic*** Launches New Patient Portal Powered by BridgeInteract	text
121	Penn gene therapy pioneer Jim Wilson explains why he's leaving	text
122	Keytruda adds new FDA approval for a rare form of mesothelioma	text
123	Hackensack Meridian Health Foundation Raises More Than $10 Million at Annual Gala, Honors Peter Cancro and Eli Manning and Publicly Launches $1 Billion Be The Difference Campaign	text
124	AscellaHealth Podcast Pulse: AscellaHealth Launches Podcast Series Addressing Key Issues Impacting Life Sciences & Payers within the Specialty Healthcare Ecosystem	text
125	Astellas CEO talks future beyond Xtandi as j***anese drugmaker puts roots in Boston	text
126	-	image
127	-	image
128	-	image
129	Tweets by BiotechNetworks	text

Nofollow Link Count : 0

Title Link Count : 0

DOMAIN INFORMATION

Domain Registrar	TUCOWS DOMAINS INC.
Registration Date	2020-11-19 5 years, 5 months, 7 days ago
Last Modified	2023-11-08 2 years, 5 months, 19 days ago
Expiration Date	2024-11-19 Expired

Domain Nameserver Information

Host	IP Address	Country
ns1.siteground.net	75.2.77.104	United States
ns2.siteground.net	99.83.229.113	United States

Whois raw

Domain Name: biotechnetworks.org
Registry Domain ID: 0f68b1cf420f44b3aaf945353c2baf0c-LROR
Registrar WHOIS Server: whois.tucows.com
Registrar URL: http://www.tucows.com
Updated Date: 2023-11-07T23:54:48Z
Creation Date: 2020-11-18T21:48:28Z
Registry Expiry Date: 2024-11-18T21:48:28Z
Registrar: Tucows Domains Inc.
Registrar IANA ID: 69
Registrar Abuse Contact Email: domainabuse@tucows.com
Registrar Abuse Contact Phone: +1.4165350123
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Registry Registrant ID: REDACTED FOR PRIVACY
Registrant Name: REDACTED FOR PRIVACY
Registrant Organization: Data Protected
Registrant Street: REDACTED FOR PRIVACY
Registrant City: REDACTED FOR PRIVACY
Registrant State/Province: CA
Registrant Postal Code: REDACTED FOR PRIVACY
Registrant Country: US
Registrant Phone: REDACTED FOR PRIVACY
Registrant Phone Ext: REDACTED FOR PRIVACY
Registrant Fax: REDACTED FOR PRIVACY
Registrant Fax Ext: REDACTED FOR PRIVACY
Registrant Email: Please query the RDDS service of the Registrar of Record identified in this output for information on how to contact the Registrant, Admin, or Tech contact of the queried domain name.
Registry Admin ID: REDACTED FOR PRIVACY
Admin Name: REDACTED FOR PRIVACY
Admin Organization: REDACTED FOR PRIVACY
Admin Street: REDACTED FOR PRIVACY
Admin City: REDACTED FOR PRIVACY
Admin State/Province: REDACTED FOR PRIVACY
Admin Postal Code: REDACTED FOR PRIVACY
Admin Country: REDACTED FOR PRIVACY
Admin Phone: REDACTED FOR PRIVACY
Admin Phone Ext: REDACTED FOR PRIVACY
Admin Fax: REDACTED FOR PRIVACY
Admin Fax Ext: REDACTED FOR PRIVACY
Admin Email: Please query the RDDS service of the Registrar of Record identified in this output for information on how to contact the Registrant, Admin, or Tech contact of the queried domain name.
Registry Tech ID: REDACTED FOR PRIVACY
Tech Name: REDACTED FOR PRIVACY
Tech Organization: REDACTED FOR PRIVACY
Tech Street: REDACTED FOR PRIVACY
Tech City: REDACTED FOR PRIVACY
Tech State/Province: REDACTED FOR PRIVACY
Tech Postal Code: REDACTED FOR PRIVACY
Tech Country: REDACTED FOR PRIVACY
Tech Phone: REDACTED FOR PRIVACY
Tech Phone Ext: REDACTED FOR PRIVACY
Tech Fax: REDACTED FOR PRIVACY
Tech Fax Ext: REDACTED FOR PRIVACY
Tech Email: Please query the RDDS service of the Registrar of Record identified in this output for information on how to contact the Registrant, Admin, or Tech contact of the queried domain name.
Name Server: ns1.siteground.net
Name Server: ns2.siteground.net
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of WHOIS database: 2024-09-25T16:01:29Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
Terms of Use: Access to Public Interest Registry WHOIS information is provided to assist persons in determining the contents of a domain name registration record in the Public Interest Registry registry database. The data in this record is provided by Public Interest Registry for informational purposes only, and Public Interest Registry does not guarantee its accuracy. This service is intended only for query-based access. You agree that you will use this data only for lawful purposes and that, under no circumstances will you use this data to (a) allow, enable, or otherwise support the transmission by e-mail, telephone, or facsimile of mass unsolicited, commercial advertising or solicitations to entities other than the data recipient's own existing customers; or (b) enable high volume, automated, electronic processes that send queries or data to the systems of Registry Operator, a Registrar, or Identity Digital except as reasonably necessary to register domain names or modify existing registrations. All rights reserved. Public Interest Registry reserves the right to modify these terms at any time. By submitting this query, you agree to abide by this policy.  The Registrar of Record identified in this output may have an RDDS service that can be queried for additional information on how to contact the Registrant, Admin, or Tech contact of the queried domain name.

WEBSITE SERVER INFORMATION